John A. Lewicki

This profile gathers the share dealings of John A. Lewicki across 2 companies, led by OncoMed Pharmaceuticals Inc and Mereo BioPharma Group plc. We count 22 filings; the first trade dates from 6 January 2016 and the latest from 13 September 2024.

Sales make up the whole of the open-market record (15 sales, €323k). The rest of the record consists of 3 share grants and 3 option exercises. Since January 2024: no purchases and 4 sales on the market.

On 16 September 2024 came the latest disclosure, an open-market sale for €42k in Mereo BioPharma Group plc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.